| You
are in Research To
Smoke Or Not To Smoke: A Cannabis Odysseyby
Lester Grinspoon, M.D., speech at the NORML 2001 Conference Washington, DC on
20 April 2001 (Note:
Dr Grinspoon is the Chair, NORML Foundation ( http://www.norml.org
) and the author of Marihuana Reconsidered and Marihuana the Forbidden Medicine
http://www.rxmarihuana.com/ )
Every
age has its peculiar folly and if Charles Mackay, the author of the mid 19th century
classic, Extraordinary Popular Delusions and the Madness of Crowds were alive
today he would surely see "cannabinophobia" as a popular delusion along
with the "tulipmania" and "witch hunts" of earlier ages. I
believe that we are now at the cusp of this particular popular delusion which
to date has been responsible for the arrest of over twelve million US citizens.
I also believe that future historians will look at this epoch and recognize it
as another instance of the "madness of crowds." Everyone in this room
has already arrived at this understanding, but for some of us enlightenment came
later than we would have wished. Consistent with the goal of my Uses of Marijuana
Project ( http://www.marijuana-uses.com/ ) of encouraging users to write about
their involvement with cannabis, I thought I would share something of my cannabis
enlightenment, a story that now spans a third of a century. In
every life there occur seminal events that modify the seemingly established trajectory
of one's personal history. For
me, three of the four big ones were, in chronological order, the decision to go
to medical school, the extraordinary good fortune of meeting the woman I married,
and the gift of children. The fourth was my improbable encounter with cannabis,
an event that divided my life into two eras; the before cannabis era, and the
cannabis era (my son David refers to these phases of my life as BC and AD for
before cannabis and after dope). My cannabis era began to unfold in 1967. As the
senior author of a book on schizophrenia, I found myself with what I estimated
would be two to three relatively free months before my co-authors would finish
their chapters. Because I had become concerned that so many young people were
using the terribly dangerous drug marijuana, I decided to use the time to review
the medical literature so that I could write a reasonably objective and scientifically
sound paper on the harmfulness of this substance. Young people were ignoring the
warnings of the government, but perhaps some would seriously consider a well-documented
review of the available data. So I began my systematic review of the medical and
scientific literature bearing on the toxicity mental and physical of marijuana.
It never occurred to me then that there were other dimensions of this drug that
warranted exploration. During
my initial foray into this literature I discovered, to my astonishment, that I
had to seriously question what I believed I knew about cannabis. As I began to
appreciate that what I thought I understood was largely based on myths, old and
new, I realized how little my training in science and medicine had protected me
against this misinformation. I had become not just a victim of a disinformation
campaign, but because I was a physician, one of its agents as well. Believing
that I should share my skepticism about the established understanding of marijuana,
I wrote a long paper which was published in the now-defunct International Journal
of Psychiatry; a shorter version was published as the lead article in the December
1969 issue of Scientific American. In these papers I questioned whether the almost
ubiquitous belief that marijuana was an exceedingly harmful drug was supported
by substantial data to be found in the scientific and medical literature. While
there was little reaction to the paper published in the psychiatric journal, there
was much interest in the Scientific American article. Within
a week of the appearance of the article, I received a visit from the associate
director of the Harvard University Press, who suggested that I consider writing
a book on marijuana. I
found the idea both attractive and daunting. The subject was worthy of a book-length
exposition, and I would have a reason to deepen my exploration of this fascinating
and harmful misunderstanding. And there was another reason, perhaps the most compelling
of all . The one aspect of my work that interested my twelve-year old son Danny
was my study of marijuana. His illness began in July of 1967, just about the time
I had decided to learn about the dangers of marijuana. He was diagnosed with acute
lymphocytic leukemia, and his prognosis was, of course, grave. He was both excited
and pleased when I told him that I had decided to write a book on marijuana. A
few weeks later I learned that the Board of Syndics of the Harvard University
Press had rejected the book proposal as too controversial. Until that moment I
was unaware of the existence of this board which must approve every book published
by the Press. An image of the Rembrandt painting "Syndics of the Cloth Guild"
came to mind: a group of serious-looking, longhaired men sitting around a table,
exuding caution and conservatism. I was disappointed but not surprised that they
rejected this proposal; it was the first instance of academic resistance to my
work in this area. I could have signed on immediately with a trade publisher that
offered the prospect of selling more books. But I believed that a conservative,
prestigious press would lend more credibility to a book that promised to be quite
controversial. The director of the press was undaunted; he believed that he could
persuade the Syndics to reverse their decision. And so he did. It
turned out to be a much bigger project than I had anticipated. I found that I
had more than the medical and scientific literature to review. Because so much
of the misinformation and myths about this drug had their origins in the gaudy
writings of the French Romantic Literary Movement, I felt compelled to examine
the works of Theophile Gautier, Charles Baudelaire, and other members of Le Club
des Haschischins, as well as those of Bayard Taylor and Fitz Hugh Ludlow. It was
fascinating to learn that much of the mythology about cannabis that was being
promulgated by the US government had its origins in these writings. It is difficult
to imagine that Harry Anslinger (our first drug tsar) was directly familiar with
these 19th-century authors, but clearly some of their hyperbolic descriptions
of the cannabis experience, largely products of effusive imagination under the
influence of copious amounts of hashish, are echoed al most a century later in
the "teachings" of Harry Anslinger. I
had come to understand that marijuana was not addicting in the usual, rather vague
understanding of that word, but I certainly got hooked on learning about it. I
was fascinated by my growing understanding of how little I actually knew about
this drug, and even more so by the many false beliefs I had held with such conviction.
It soon dawned on me that I, like most other Americans, had been brainwashed,
that I was a part of this madness of the crowd. And the more I learned about cannabis,
the more it seemed to be capable of providing experiences which would be worth
exploring personally sometime in the future. In the meantime, I felt like an explorer
sailing an inaccurately and inadequately mapped ocean. Where
earlier cartographers had found many shoals, I found few; where others found barren
and dangerous islands, I saw lands that looked increasingly interesting as I drew
closer. The clearer the view, the greater the temptation to land and make a direct
exploration, but I reminded myself that the point of this trip was to chart the
ledges and shoals, not to explore forbidden lands to look for riches. Long before
I decided to land, more than a year after the publication of Marihuana Reconsidered
in 1971, it had become inescapably clear that while marijuana was not harmless,
its harmfulness lay not so much in any inherent psychopharmacological property
of the drug but in the social and legal consequences of our firmly held misbeliefs. After
the publication of "Marihuana Reconsidered "I was often asked about
my personal experience with cannabis. Some questioners were skeptical when I replied
that I had never used it: " What, you wrote a book about marijuana and you
never experienced it!" The implication was that inexperience would invalidate
my claim to expertise. I would defensively respond, "I have written a book
on schizophrenia and I have never experienced that." It was not until some
years later that I realized that there was validity to this criticism of my lack
of personal experience with cannabis. Especially in the later phases of this research
and writing, I had flirted with the idea of trying marijuana, not because I believed
at that time that it would inform my work, but because it appeared to be such
an interesting experience. I decided against it out of fear that it would compromise
my goal of producing as objective a statement as I could. Of course the further
I pursued the subject the more I realized how difficult, if not impossible, it
would be to produce a truly neutral and objective statement. But I was not about
to add to this difficulty by personally exploring marijuana at this time even
though the temptation to do so became greater as I learned more about it. As
it turns out, it is well that I did not try it; had I done so, as you will soon
learn, I might have concluded that the "drug" induced nothing but a
placebo effect, that the whole thing was an enormous scam or, at the very least,
much ado about nothing. While it was important to me that "Marihuana Reconsidered"
not be an N-of-1 study (that is, a study generalizing from the experience of one
subject), I now know that it is, in some ways, less well informed, if somewhat
more objective, than it might have been had it been written by an experienced
cannabis user. There is much about schizophrenia that I did not understand (and
still do not) when I wrote that book, but there was no way in which personal experience
could address that weakness. I had a choice where marijuana was concerned, but
I believed at the time that the best shot at objectivity and scientific legitimacy
lay in abstinence. I
had another reason for postponing personal experience with cannabis. If the book
were successful, I expected to be called as an expert witness before legislative
committees and in courtrooms. I correctly anticipated that some of my interrogators
would want to know whether I had ever used cannabis, and I wanted to be able to
deny it so as to preserve at least the appearance of objectivity. In the beginning
I did not believe this question unfair. It seemed to me to be no different from
other questions about my credentials. But I soon learned that when it was asked,
it was almost always put by a legislator, lawyer, judge, or media person who was
hostile to the suggestion that cannabis might not be as harmful as he firmly believed.
It became increasingly clear that the question was asked, not in the spirit of
learning more about the context of my understanding of this drug, but rather in
the hope that I would answer affirmatively and that this would discredit my testimony.
More than a year after the publication of the book I was testifying before a legislative
committee when a senator who had already revealed his hostility asked, "Doctor,
have you ever used marijuana?" Perhaps because I was irritated by the hostility
reflected in his previous questions and his sneering tone of voice, I replied,
"Senator, I will be glad to answer that question if you will first tell me
whether if I answer your question affirmatively, you will consider me a more or
less credible witness?" The senator, visibly upset by my response, angrily
told me that I was being impertinent and left the hearing room. That was the moment
that I decided that the time had come. Later
that week Betsy and I went to a party in Cambridge where we knew that some guests
would be smoking marijuana. Ever since a review of Marihuana Reconsidered had
appeared on the front page of the New York Times Book Review (under the banner,
"The best dope on pot so far") people had been offering us marijuana,
and we had been politely and often a little apologetically declining it. Those
guests who knew of our previously resolute abstemiousness were surprised when
we decided to join them . We were cautious, as cannabis-naive people should be,
as we inhaled our first tokes ever. Shortly afterward my first and only unpleasant
cannabis experience began. A lit joint was passed around a small circle and we
took turns inhaling big, noisy puffs and holding them in for a few seconds. One
by one the others said they had had enough and waved off the passing joint; they
were high, or at least claimed to be. I asked Betsy, "Do you feel anything?" "Not
a thing!" "Neither
do I." We
were disappointed. We had been looking forward to this initiation for several
years. I had come to expect so much from the experience, from the magical possibilities
of this subtly altered state of consciousness and now nothing! I began to wonder;
was this all there was to it? Was
my acceptance of the claims of cannabis aficionados just as naive as my earlier
belief in the propaganda disseminated by the Harry Anslinger truth squad and its
descendants? Could it be true that all I had accomplished in over three years
of intensive research was to swing the pendulum of my gullibility from one extreme
to the other? Soon
my disappointment gave way to a palpable level of anxiety. Was it possible that
I had spent all this time studying what must be for some people an enormously
persuasive placebo? Would not the author of a book which took as a basic premise
that marijuana is a real drug be considered fraudulent? I tried to reassure myself.
I reminded myself that I had, after all, carefully explained to the reader that
many if not most people do not get high the first time they use marijuana. I was
mindful that it was not until his sixth attempt that a very close friend experienced
a high. At
that time I believed that the anxiety I experienced that night was generated by
a precipitous loss of confidence in my newly arrived-at understanding of cannabis,
an unshakable belief that after more than three years of hard work, I had gotten
it wrong and as a consequence had misled a lot of people certainly sufficient
grounds for a good dose of anxiety. It was not until much later, both chronologically
and in my experience with "stoned thinking", that I began to question
that explanation. Usually when anxiety arises as an appropriate response to a
real threat, it evaporates once that threat is no longer present or can be satisfactorily
demonstrated never to have existed in the first place. But the anxiety I experienced
that night did not respond to my marshaling of convincing evidence that cannabis
was not a bogus drug and reassuring myself that it is not unusual for marijuana
neophytes to fail at getting high on the first attempt. It's as though that anxiety
had a life all of its own, unattached to any real threat, not unlike that of a
general anxiety disorder. The difference was that there was not a trace of it
when I awoke the next morning. I was puzzled by this episode, and it occurred
to me only years later while I was smoking cannabis that I might have actually
achieved a high that first night, an "anxiety high," not the kind I
had expected. This was certainly not impossible; a small percentage of people
who use cannabis for the first time experience some degree of anxiety. Just because
they have never used it before, they don't understand the importance of self-titration
(adjusting the dose in response to the perceived effects). In any event, titration
is difficult because they have not yet learned to recognize the subtle signs of
the intoxication. There are even a few people who always get anxious when they
use marijuana. Among the Rastafarians of Jamaica, these folks are considered slightly
deviant but are understandably excused with the expression, "He don't have
a head for ganja!" This
was not a problem with my head, for a week or so later we smoked cannabis and
again neither Betsy nor I noticed any change in our states of consciousness that
would even remotely suggest that we were high. Thankfully, however, I was not
the least bit anxious this time only disappointed again. Finally, on our third
attempt, we were able to reach the promised high. Our awareness of having at last
crossed the threshold arrived gradually. The first thing I noticed, within a few
minutes of smoking, was the music; it was "Sgt. Pepper's Lonely Hearts Club
Band." This music was not unfamiliar to me, as it was a favorite of my children,
who constantly filled the house with the sound of the Beatles, the Grateful Dead
and other popular rock bands of the time. They frequently urged me to get my "head
out of classical music and try listening to rock." It was impossible not
to listen to rock when they were growing up, but it was possible for me, as it
was for many parents of my generation, not to hear it. On that evening I did "hear"
it. It was for me a rhythmic implosion, a fascinating new musical experience!
It was the opening of new musical vistas, which I have with the help of my sons
continued to explore to this very day. A year later, I related this story to John
Lennon and Yoko Ono, with whom I was having dinner. (I was to appear the next
day as an expert witness at the Immigration and Naturalization Service hearings
that Attorney General John Mitchell had engineered as a way of getting them out
of the country on marijuana charges after they became involved in anti-Vietnam
War activities.) I told John of this experience and how cannabis appeared to make
it possible for me to "hear" his music for the first time in much the
same way that Allen Ginsberg reported that he had "seen" Cezzanne for
the first time when he purposely smoked cannabis before setting out for the Museum
of Modern Art. John was quick to reply that I had experienced only one facet of
what marijuana could do for music, that he thought it could be very helpful for
composing and making music as well as listening to it. In
my next recollection of that evening, Betsy and I and another couple were standing
in the kitchen in a circle, each of us in turn taking bites out of a Napoleon.
There was much hilarity as each bite forced the viscous material between the layers
to move laterally and threaten to drip on the floor. It seemed a riotous way to
share a Napoleon. But the most memorable part of the kitchen experience was the
taste of the Napoleon. None of us had ever, "in our whole lives", eaten
such an exquisite Napoleon! "Mary, where in the world did you find these
Napoleons?" "Oh, I've had their Napoleons before and they never tasted
like this!" It was gradually dawning on me that something unusual was happening;
could it be that we were experiencing our first cannabis high? We
drove home very cautiously. In fact, one of the observations I made on the way
home was how comfortable I, an habitual turnpike left-laner, was in the right-hand
lane with all those cars zipping past me. It seemed like a very long time before
we arrived home. Not that we were in a rush the ride was very pleasant. Time passed
even more slowly between our arrival and our going to bed, but once we did, we
knew with certainty that we had finally been able to achieve a marijuana high. And
that marked the beginning of the experiential facet of my cannabis era, a development
that furthered my education about the many uses of this remarkable drug. I
was 44 years old in 1972 when I experienced this first marijuana high. Because
I have found it both so useful and benign I have used it ever since. I have used
it as a recreational drug, as a medicine, and as an enhancer of some capacities.
Almost everyone knows something of its usefulness as a recreational substance,
growing numbers of people are becoming familiar with its medical utility, but
only practiced cannabis users appreciate some of the other ways in which it can
be useful. It
has been so useful to me that I cannot help but wonder how much difference it
would have made had I begun to use it at a younger age. Because it has been so
helpful in arriving at some important decisions and understandings, it is tempting
to think that it might have helped me to avoid some "before cannabis era"
bad decisions. In
fact, now, when I have an important problem to solve or decision to make, I invariably
avail myself of the opportunity to think about it both stoned and straight. I
cannot possibly convey the breadth of things it helps me to appreciate, to think
about, to gain new insights into. But I would like to share several not too personal
instances. For
example, let me tell you about the worst career choice I have ever made; it was
my decision to apply to the Boston Psychoanalytic Institute as a candidate for
training in psychoanalysis. I began this training, which was enormously costly
in both time and money, in 1960 and graduated seven years later. Although I developed
some skepticism about certain facets of psychoanalytic theory during training,
it was not sufficient to dull the enthusiasm with which I began treating patients
psychoanalytically in 1967 (coincidentally, the same year I began to study cannabis).
It was not until about the mid '70s that my emerging skepticism about the therapeutic
effectiveness of psychoanalysis began to get uncomfortable. This discomfort was
catalyzed by cannabis. On those evenings when I smoke marijuana it provides, among
other things, an invitation to review significant ideas, events and interactions
of the day; my work with patients is invariably on that agenda. This cannabis
review-of-the-day is almost invariably self-critical, often harshly so, and the
parameters within which the critique occurs are inexplicably enlarged. My psychotherapy
patients, patients who sat opposite me and who could share eye contact and free
verbal exchange, always appeared to be making better progress than my psychoanalytic
patients. I was generally satisfied with my work with the former, and invariably
at first impatient and later unhappy with the lack of progress made by patients
on the couch. There is little doubt that it was the cumulative effect of these
stoned self-critiques that finally, in 1980, compelled me to make the decision
not to accept any new psychoanalytic patients. Nevertheless, I remained a dues
paying member of the Boston Psychoanalytic Institute because I believed that the
problem was mine; other psychoanalysts could make it work, but somehow I could
not. After much more straight and stoned thinking about this over the course of
a few years, I finally arrived at the conclusion that the problem was not mine,
that psychoanalysis as a therapeutic modality was not very useful, and at that
point I resigned from the Institute. As I look back on it, I do not think that
I did any worse than other psychoanalysts did. Analysts
are insulated from any concern that the patient is not making progress by the
shared expectation that the process will take a long time and, even more so, by
the powerful transference which, among other things, gratifies the analyst's narcissism
and supports the patient's (and often the analyst's) fantasy of the analyst's
omniscience. Under these circumstances it is difficult for the psychoanalyst to
be critical of his own work. In order to do so, he has to be equipped with a powerful
"bull shit" detector. I am convinced that cannabis helps me to fine
tune this detector and that this enhanced capacity helped facilitate my understanding
that I had made an enormous mistake when I decided to become a psychoanalyst. The
decision to resign from the Institute was very difficult, a little like deciding
to get a divorce after more than a decade of marriage. But
I have no doubt that it was the only way I could deal with this growing discomfort
and rectify what was now clearly seen as a mistake. Some of my former psychoanalyst
colleagues might believe, among other things, that I have merely traded my involvement
in what I considered a macro-delusional system for immersion in an inverse micro
version. Such
a possibility notwithstanding, I am indebted to cannabis for the help it provided
me in achieving the clarity necessary to arrive at this most difficult decision. Cannabis
can also be used as a catalyst to the generation of new ideas. Experienced cannabis
users know that under its influence new ideas flow more readily than they do in
the straight state. They also understand that some are good and others are bad
ideas; sorting them out is best done while straight. In the absence of an agenda,
the ideas are generated randomly or as close or distant associations to conversation,
reading, or some perceptual experience. It is sometimes worthwhile to have a stoned
go at trying to solve a particular problem. An illustration comes to mind. In
1980, during my tenure as Chairperson of the Scientific Program Committee of the
American Psychiatric Association (APA) I "invented" and then edited
the first three volumes of the Annual Review of Psychiatry, a large book which
is still published yearly by the APA. Mindful of how much money this annual publication
was earning for the APA, the chief of our sub-department of psychiatry asked me
to put my "thinking-cap" on and come up with a way for the Harvard Department
of Psychiatry to supplement its shrinking budget. Taking his request seriously,
I smoked that night for the express purpose of trying to generate relevant ideas.
Within days, at a meeting in the Dean's office, it was agreed that the idea I
arrived at that evening would be pursued the publication of a monthly mental health
letter. The first edition of The Harvard Mental Health Letter appeared in July
1984 and it soon achieved considerable success as an esteemed mental health publication
and a steady source of income to the Harvard Medical School Department of Psychiatry.
Would the idea have come or come as easily in a straight state? Maybe. All
through the seemingly endless heated discourse on cannabis in this country over
the last three decades, little has been said or written about its many uses. The
overwhelming preponderance of funding, research, writing, political activity,
and legislation have been centered on the question of its harmfulness. The 65
year old debate, which has relatively recently included discussion of its usefulness
and safety as a medicine, has never been concerned with its non-medicinal uses;
it is always limited to the question of how harmful it is and how a society should
deal with the harm it is alleged to cause. It is estimated that 76 million Americans
have used cannabis and more than 10 million use it regularly. They use it in the
face of risks that range from opprobrium to imprisonment. From the time I began
my studies of marijuana, 12 million citizens of this country have been arrested
for marijuana offenses. The number of annual marijuana arrests is increasing,
and in 1999 over 700,000 people were arrested on marijuana charges, 88 percent
of them for possession. Because the government allows confiscation of property
in drug cases, many have lost valued possessions ranging from automobiles to homes.
Most have to undertake expensive legal defenses and some have served or will serve
time in prison. Unless we are prepared to believe that all these people are driven
by uncontrollable "Reefer Madness" craving, we must conclude that they
find something in the experience attractive and useful. And yet there is very
little open exploration of these uses with the growing exception of its value
as a medicine. Even here, government officials want to mute the discussion out
of a fear expressed by the chief of the Public Health Service when in 1992 he
discontinued the only legal avenue to medicinal marijuana: "If it is perceived
that the Public Health Service is going around giving marijuana to folks, there
would be a perception that this stuff can't be so bad... it gives a bad signal."
The government has, until very recently, refused to knowledge that cannabis has
any value, even medicinal, but there are millions of citizens who have discovered
through their own experience that it has a large variety of uses they consider
valuable and that the health costs are minimal. This
large population of marijuana users is a subculture, one that has been present
in this country since the 1960s. Three decades ago it was an open, vocal, active,
and articulate culture on and off the campus. Today it is silent and largely hidden
because most users, understandably, do not want to stand up and be counted. They
have more than the law to fear. Urine testing is now a fact of life in corporate
America; a positive test result can lead, at the very least, to a stint in a "drug
treatment" program, and at most, to the loss of a job, career destruction,
even imprisonment. Users are very mindful of this minefield, and most find ways
around it. Even more pervasive and in some ways more pernicious is the stigmatization
attached to cannabis use. Young people often experience little of this, at least
among their friends. But as they grow older and move into increasingly responsible
and visible positions they become much more guarded. Many believe, correctly,
that colleagues would regard them as deviant if they knew. This stigmatization
is abetted by the media, which have created and perpetrated a stereotyped image
of "potheads" as young, hirsute, slovenly dressed ne'er-do-wells or
disreputable, irresponsible, and socially marginal hedonists who use marijuana
only to hang out and party. One reason for the fierce resistance to marijuana
is the fear that it will somehow taint middle-class society with the "pothead"
culture. There
is no denying that many, especially young people, use marijuana primarily for
"partying and hanging out" in the same way that many more use beer.
And most non-users, until they become aware of its medical value, believe that
smoking to party and hang out pretty much defines the limits of its usefulness.
This stereotype is powerful, and reactions ranging from puzzlement to outrage
greet claims that this party drug could be useful as medicine or for any other
purposes. People
who make claims about its usefulness run the risk of being derided as vestigial
hippies. Under these circumstances it is not surprising that most people who use
cannabis do so behind drawn curtains, alone or with others who share some appreciation
of its value. It
is unfortunate that those who, from personal experience, are aware of its usefulness
are so reluctant to be public about it. I believe it would be good for the country
if more people in business, academic and professional worlds were known to be
marijuana users. The government has been able to pursue its policies of persecution
and prosecution largely because of the widespread false belief that cannabis smokers
are either irresponsible and socially marginal people or adolescents who "experiment",
learn their lesson, and abandon all use of the drug. That lie is unfortunately
perpetuated when those who know better remain silent. It's time to let the truth
come out. Just as the gay and lesbian out-of-the-closet movement has done so much
to decrease the level of homophobia in this country, when the many people of substance
and accomplishment who use cannabis "come out", it will contribute much
to the diminution of cannabinophobia. Not
many well-known people are identified as users of cannabis. A few politicians
have been outed by their enemies (one went so far as to claim that he did not
inhale), and some would-be political appointments have failed because of a history
of marijuana use. Occasionally a screen star, musician or professional athlete
is arrested for possession. Aside from Allen Ginsberg, some popular musicians,
and a few notables from the Beat and hippie movements, few people in the public
eye have voluntarily acknowledged cannabis use. Except
for one well-known scientist, the physicist Richard Feynman, academics have been
most cautious. Feynman, by courageously acknowledging his ongoing use of marijuana,
won the respect and appreciation of many and the enmity of others. Fear of "coming
out" is, of course, not without foundation. As long as the present stereotyped
understanding of marijuana use and its effects continues to prevail, anyone who
acknowledges using it will risk being taken less seriously from then on. It is
thought that potheads could not possibly be considered mature, serious, responsible,
and credible. Yet
only those who actually use cannabis can teach us how useful it is. There
was a time not so long ago when it was generally assumed that any use of marijuana
was "merely recreational." This was certainly true at the time I wrote
"Marihuana Reconsidered". The chapter on marijuana as medicine (The
Place of Cannabis and Medicine) was concerned with past (19th and early 20th century)
and potential uses; there was no overt and little covert use of cannabis as a
medicine at that time. Now, there are many thousands of patients who use cannabis
medicinally. And as the ranks of these patients grow, so does the number of people
who observe for themselves how relatively benign this substance is. Seventy-four
percent of Americans presently believe that cannabis should be made available
as a medicine; very few people would have held this belief in 1971. Currently
it is generally thought that there are two generic categories of marijuana use:
recreational and medical. But in fact many uses do not ?fit into these categories
without stretching their boundaries to the point of distortion; they fall into
a third category, one that is more diverse and for that reason difficult to label.
It includes such disparate uses as the magnification of pleasure in a host of
activities ranging from dining to sex, the increased ability to hear music and
see works of art, and the ways in which it appears to catalyze new ideas, insights
and creativity, to name a few. Furthermore, at its edges, which are fuzzy, there
is some conflation with both medicine and recreation. Yet, the preponderance of
these uses falls into this broad and distinctive third category that I call enhancement. This
is the class of uses which is generally the least appreciated or understood by
non-cannabis users. It
is also the case that some people who use or who have used marijuana may not be
aware of some if not most of the enhancement possibilities. This may be particularly
true of young people whose predominant interest in the drug revolves around its
ability to promote sociability, jocularity and fun. All are aware of the psychopharmacologically
induced properties, such as enhancement of appetite. This is very common and manifests
itself as the "munchies", which may be a problem for frequent users
who have marginal ability to control their weight but a boon for people who suffer
from serious appetite loss, such as patients with AIDS. But most of these enhancement
capacities are not simple manifestations of inherent psychopharmacological properties
of the drug; some appear to require some degree of learning to develop. A person
who wants to learn to use cannabis in this multiplicity of ways has first of all
to know about these possibilities, and then to accumulate experience in their
explorations. One
category of cannabis utility that we have studied is its usefulness as a medicine. Because
there is not at this time a systematic clinical literature on the medicinal uses
of cannabis, James B. Bakalar and I asked patients to share their experiences
with cannabis as a medicine for our book, Marihuana, the Forbidden Medicine (Yale
University Press, 1993, 1997). We
supplemented these patient accounts with our own clinical experience and what
we could glean from the medical literature. This work has occasionally been criticized
as being largely comprised of "anecdotal evidence" not supported by
(so-far non-existent) large double-blind placebo controlled studies, and therefore
not to be taken seriously. Yet, marijuana's recently rehabilitated reputation
for and growing acceptance as a medicine derives from anecdotal accounts. There
will come a day, I hope in the not too distant future, when cannabis is scrutinized
in the same way that other new potentially useful medicines are. Anecdotal evidence
is not as persuasive as that from double-blind placebo controlled studies, the
more scientifically sound modern medical approach to the safety and efficacy of
new therapeutics. As the results of such studies become available we may be compelled
to modify our estimate of the clinical usefulness of cannabis. At this time, however,
it is difficult to imagine that future studies will subtract much from the clinical
experience-driven perception that cannabis is a remarkably versatile medicine
with relatively little toxicity. It
is my intention to roughly follow the same format in the Uses of Marijuana Project
( http://www.marijuana-uses.com/ ). While I will attempt to illuminate the various
uses of cannabis through literary accounts and by sharing some of my own experiences,
the prime source of what I hope will be a fairly comprehensive understanding of
the uses of this versatile drug will come from contemporary users. Some will identify
themselves; others will prefer to remain anonymous for reasons that have already
been noted. Either way, I hope to present enough information about the witness
to put his or her account into a meaningful context. Unlike medicinal use, which
will eventually be befitted with scientific costume, an understanding of those
uses which fall into the category of enhancement will probably always be based
on anecdotal accounts; it is unlikely that marijuana's capacity for the enhancement
of sexual pleasure, for example, will ever be the subject to a modern scientific
(double-blind placebo-controlled) study. However,
if this ethnographic method is successful we should be able to provide a reasonably
proximate picture of the varieties and value of cannabis use in contemporary society.
And in so doing, by telling our stories, we cannabis users can make a significant
contribution to the demise of cannabinophobia, one of our age's most damaging
popular delusions. In
the meantime, Betsy and I are gradually being given the opportunity to explore
another dimension of the ways in which cannabis can be valuable; we are discovering
its usefulness in the task of achieving reconciliation with the aging process,
including coming to terms with the inevitable physical and emotional aches, deficits
and losses. Cannabis
also enhances our appreciation of the time we have, now that we are emeritus,
to enjoy our children, grandchildren and friends, literature, music and travel,
and our daily walks in the New England woods. Of
still more importance, it helps us to realize the wisdom of Robert Browning's
words, "Grow old along with me! The best is yet to be..." |